Evidence That Humans Metabolize Benzene via Two Pathways

Background Recent evidence has shown that humans metabolize benzene more efficiently at environmental air concentrations than at concentrations > 1 ppm. This led us to speculate that an unidentified metabolic pathway was mainly responsible for benzene metabolism at ambient levels. Objective We statistically tested whether human metabolism of benzene is better fitted by a kinetic model having two pathways rather than one. Methods We fit Michaelis-Menten-like models to levels of urinary benzene metabolites and the corresponding air concentrations for 263 nonsmoking Chinese females. Estimated benzene concentrations ranged from less than 0.001 ppm to 299 ppm, with 10th and 90th percentile values of 0.002 ppm and 8.97 ppm, respectively. Results Using values of Akaike’s information criterion obtained under the two models, we found strong statistical evidence favoring two metabolic pathways, with respective affinities (benzene air concentrations analogous to Km values) of 301 ppm for the low-affinity pathway (probably dominated by cytochrome P450 enzyme 2E1) and 0.594 ppm for the high-affinity pathway (unknown). The exposure-specific metabolite level predicted by our two-pathway model at nonsaturating concentrations was 184 μM/ppm of benzene, a value close to an independent estimate of 194 μM/ppm for a typical nonsmoking Chinese female. Our results indicate that a nonsmoking woman would metabolize about three times more benzene from the ambient environment under the two-pathway model (184 μM/ppm) than under the one-pathway model (68.6 μM/ppm). In fact, 73% of the ambient benzene dose would be metabolized via the unidentified high-affinity pathway. Conclusion Because regulatory risk assessments have assumed nonsaturating metabolism of benzene in persons exposed to air concentrations well above 10 ppm, our findings suggest that the true leukemia risks could be substantially greater than currently thought at ambient levels of exposure—about 3-fold higher among nonsmoking females in the general population.

[1]  Hiroshi Yamazaki,et al.  Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and toluene. , 2008, Chemical research in toxicology.

[2]  Brent A. Johnson,et al.  Genetic polymorphisms and benzene metabolism in humans exposed to a wide Range of air concentrations , 2007, Pharmacogenetics and genomics.

[3]  Brent A. Johnson,et al.  Modeling Human Metabolism of Benzene Following Occupational and Environmental Exposures , 2006, Cancer Epidemiology Biomarkers & Prevention.

[4]  Brent A. Johnson,et al.  Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. , 2006, Carcinogenesis.

[5]  W. P. Watson,et al.  Evidence for the formation of Michael adducts from reactions of (E,E)-muconaldehyde with glutathione and other thiols. , 2005, Bioorganic chemistry.

[6]  S. Rappaport,et al.  Characterization and quantification of cysteinyl adducts of benzene diol epoxide. , 2005, Chemical research in toxicology.

[7]  N. Rothman,et al.  Protein adducts as biomarkers of human benzene metabolism. , 2005, Chemico-biological interactions.

[8]  Nathaniel Rothman,et al.  Hematotoxicity in Workers Exposed to Low Levels of Benzene , 2004, Science.

[9]  N. Osheroff,et al.  1,4-Benzoquinone is a topoisomerase II poison. , 2004, Biochemistry.

[10]  N. Rothman,et al.  Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. , 2004, Analytical biochemistry.

[11]  R. Hayes,et al.  Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. , 2004, The Annals of occupational hygiene.

[12]  C. Weisel,et al.  Use of stable isotopically labeled benzene to evaluate environmental exposures , 2003, Journal of Exposure Analysis and Environmental Epidemiology.

[13]  David R. Anderson,et al.  Model selection and multimodel inference : a practical information-theoretic approach , 2003 .

[14]  L. Brubaker,et al.  Variability of 24-hour voiding diary variables among asymptomatic women. , 2003, The Journal of urology.

[15]  R. Hayes,et al.  Non-linear production of benzene oxide-albumin adducts with human exposure to benzene. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  I. Hertz-Picciotto,et al.  Self-collected breath sampling for monitoring low-level benzene exposures among automobile mechanics. , 2002, The Annals of occupational hygiene.

[17]  R. Hayes,et al.  Urinary benzene as a biomarker of exposure among occupationally exposed and unexposed subjects. , 2001, Carcinogenesis.

[18]  D. Nikezić,et al.  Radon progeny dose conversion coefficients for Chinese males and females. , 2001, Journal of environmental radioactivity.

[19]  C. Skibola,et al.  Hypothesis: Phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia , 2001, Leukemia.

[20]  G. Carlson,et al.  Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes , 2000, Journal of biochemical and molecular toxicology.

[21]  M. Ingelman-Sundberg,et al.  Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression , 1999, Archives of Toxicology.

[22]  R. Hayes,et al.  Urinary excretion of phenol, catechol, hydroquinone, and muconic acid by workers occupationally exposed to benzene. , 1998, Occupational and environmental medicine.

[23]  M Dosemeci,et al.  Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. , 1997, Journal of the National Cancer Institute.

[24]  Martyn T. Smith,et al.  The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. , 1996, Environmental health perspectives.

[25]  D. Ross Metabolic basis of benzene toxicity , 1996, European journal of haematology. Supplementum.

[26]  R. Hayes,et al.  An epidemiologic study of early biologic effects of benzene in Chinese workers. , 1996, Environmental health perspectives.

[27]  E. Kenyon,et al.  Mechanistic considerations in benzene physiological model development. , 1996, Environmental health perspectives.

[28]  L. Wallace,et al.  Environmental exposure to benzene: an update. , 1996, Environmental health perspectives.

[29]  F Y Bois,et al.  Population toxicokinetics of benzene. , 1996, Environmental health perspectives.

[30]  C. Weisel,et al.  Measurement of the urinary benzene metabolite trans,trans-muconic acid from benzene exposure in humans. , 1996, Journal of toxicology and environmental health.

[31]  C. Weisel,et al.  Measurement of benzene in human breath associated with an environmental exposure. , 1996, Journal of exposure analysis and environmental epidemiology.

[32]  D. Eastmond,et al.  Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects. , 1995, Carcinogenesis.

[33]  S. Rappaport,et al.  Production of benzoquinone adducts with hemoglobin and bone-marrow proteins following administration of [13C6]benzene to rats. , 1993, Carcinogenesis.

[34]  W. Bechtold,et al.  Biological markers of exposure to benzene: S-phenylcysteine in albumin. , 1992, Carcinogenesis.

[35]  B D Goldstein,et al.  Comparative metabolism of benzene and trans,trans-muconaldehyde to trans,trans-muconic acid in DBA/2N and C57BL/6 mice. , 1990, Biochemical pharmacology.

[36]  C C Travis,et al.  Pharmacokinetics of benzene. , 1990, Toxicology and applied pharmacology.

[37]  L S Birnbaum,et al.  Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. , 1989, Toxicology and applied pharmacology.

[38]  B. Conti,et al.  Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. , 1989, Environmental health perspectives.

[39]  R. Henderson,et al.  Differences in the pathways for metabolism of benzene in rats and mice simulated by a physiological model. , 1989, Environmental health perspectives.

[40]  J K Haseman,et al.  Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. , 1989, Environmental health perspectives.

[41]  D. Koop,et al.  Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. , 1989, Toxicology and applied pharmacology.

[42]  R. Hornung,et al.  Benzene and leukemia: an epidemiologic risk assessment. , 1989, Environmental health perspectives.

[43]  Occupational exposures in petroleum refining; crude oil and major petroleum fuels. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. , 1989, IARC monographs on the evaluation of carcinogenic risks to humans.

[44]  M E Andersen,et al.  Prediction of in vivo kinetic constants for metabolism of inhaled vapors from kinetic constants measured in vitro. , 1981, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[45]  M. Aksoy,et al.  AIDS and renal failure. , 1987, The New England journal of medicine.

[46]  J. Wagoner,et al.  LEUKÆMIA IN BENZENE WORKERS , 1977, The Lancet.

[47]  P. Infante,et al.  Leukaemia in benzene workers. , 1977, Lancet.